# Dianthus Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Nov 19, 2025

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-19
- Accepted by EDGAR: Nov 19, 2025, 21:15 ET
- Period: not reported
- Accession: 0000919574-25-007115
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000091957425007115/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000091957425007115/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000091957425007115/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 19, 2025.
Source: SEC EDGAR, the filing index for accession 0000919574-25-007115. Last ingested by Listed: Oct 30, 2026, 11:27 ET. No prices; not investment advice.